Sort
53,477 grants matching “addiction”
The function of GABA/glutamate co-release in the habenula
$565,874Steven Shabel · Ut Southwestern Medical Center · R01 · FY2025 · MH
The function of GABA/glutamate co-release in the habenula
$565,874Steven Shabel · Ut Southwestern Medical Center · R01 · FY2024 · MH
Methamphetamine, HIV integration and latency in the brain
$565,868Maria Cecilia Garibaldi Marcondes · San Diego Biomedical Research Institute · R61 · FY2024 · DA
Genomic profiling mediating the protective effect of social reward on opioid craving
$565,862Marco Venniro · University Of Maryland Baltimore · R01 · FY2024 · DA
Epidemiologic Study of the Effectiveness of an ADF in Reducing Opioid Abuse
$565,845Jennifer R Havens · University Of Kentucky · R01 · FY2012 · DA
METHADONE AND HIV DRUG INTERACTIONS
$565,729Evan D Kharasch · Washington University · R01 · FY2009 · DA
The Substance Abuse Treatment to HIV care (SAT2HIV-II) Project
$565,724Bryan R Garner · Ohio State University · R01 · FY2023 · DA
Role of opioid-induced S1P/S1PR1 axis activation in neuroinflammatory reponses
$565,658Daniela Salvemini · Saint Louis University · R01 · FY2020 · DA
Role of opioid-induced S1P/S1PR1 axis activation in neuroinflammatory reponses
$565,658Daniela Salvemini · Saint Louis University · R01 · FY2019 · DA
Cognitive and Affective Mechanisms Underlying an Olfactory Approach to Modify Cigarette Craving: A Neurobehavioral Investigation
$565,635Michael Andrew Sayette · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AT
Project 1: Using toxicity testing data to test hypotheses about advanced-generation ECIGs and generate population-level predictions regarding potential regulatory action
$565,534Alan Shihadeh · Virginia Commonwealth University · U54 · FY2022 · DA
Targeting Hedonic Dysregulation to Address Chronic Pain and Opioid Misuse in Primary Care.
$565,430Eric Lee Garland · University Of Utah · R01 · FY2017 · DA
Expanding Medication Assisted Therapies in Ukraine
$565,418Frederick Lewis Altice · Yale University · R01 · FY2014 · DA
Maternal Lifestyle Study 12-15 Year Follow Up.
$565,404Charles R Bauer · University Of Miami School Of Medicine · U10 · FY2008 · DA
Cocaine Addiction and the Role of Serotonin in Orbitofrontal Cortex Function
$565,376Carl Lupica · National Institute On Drug Abuse · ZIA · FY2024 · DA
Training Program in Substance Use Disorders
$565,374Paul J Kenny · Icahn School Of Medicine At Mount Sinai · T32 · FY2025 · DA
Oral transmucosal drug delivery system for naltrexone
$565,345Hock Seng Tan · Bionex Pharmaceuticals, Llc · R44 · FY2012 · AA
Training Program in Substance Use Disorders
$565,334Paul J Kenny · Icahn School Of Medicine At Mount Sinai · T32 · FY2024 · DA
Viral Innovation Core
$565,320Kevin D Wickman · University Of Minnesota · P30 · FY2025 · DA
The Impact of Health Homes in New York State on People with Substance Use Disorde
$565,293Jon Morgenstern Morgenstern · Partnership To End Addiction · R33 · FY2017 · DA
The role of norepinephrine transporter phosphorylation in amphetamine reward
$565,271Lankupalle D Jayanthi · Virginia Commonwealth University · R01 · FY2025 · DA
Artificial Intelligence for effective communication to promote vaping cessation on social media
$565,181Dongmei Li · University Of Rochester · R01 · FY2024 · CA
Psychology Training in Alcohol Research
$565,155Mary E Larimer · University Of Washington · T32 · FY2018 · AA
Addressing Alcohol/HIV Consequences in Substance Dependence - Boston ARCH Cohort
$565,138Richard Saitz · Boston Medical Center · U01 · FY2014 · AA
Determination of Salsolinol as a Possible Marker for Alcohol Addiction
$565,060Hee-Yong Kim · Alcohol Abuse And Alcoholism · Z01 · FY2007 · AA